(FEIM) Frequency Electronics - Overview
Stock: Oscillators, Clocks, Synthesizers, GPS Modules, US5G
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 84.0% |
| Relative Tail Risk | -19.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.75 |
| Alpha | 189.25 |
| Character TTM | |
|---|---|
| Beta | 1.203 |
| Beta Downside | 0.308 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.93% |
| CAGR/Max DD | 3.47 |
Description: FEIM Frequency Electronics January 02, 2026
Frequency Electronics Inc. (NASDAQ: FEIM) designs, develops, manufactures, markets and sells precision time- and frequency-control components used in microwave integrated circuits. The firm operates through two business units: FEI-NY, which supplies timing products for communication satellites, terrestrial cellular networks and U.S. defense systems, and FEI-Zyfer, which offers GPS-based secure-communication technologies and wireline telecom gear-including equipment for the emerging US 5G rollout. The company is headquartered in Mitchel Field, New York, and serves customers across the United States, Europe and Asia.
Key sector drivers that affect FEIM’s outlook include the global surge in satellite broadband deployments (projected to grow at a CAGR of ~12% through 2030) and the accelerating rollout of 5G infrastructure, which together boost demand for high-precision timing solutions. Recent quarterly filings (Q4 2024) show FEIM’s revenue grew 9% YoY to $112 million, while its gross margin expanded to 38% as higher-margin defense contracts offset modest pricing pressure in the commercial telecom segment. The company’s cash conversion cycle has tightened to 45 days, reflecting improved working-capital management.
Analysts should monitor the U.S. defense budget trends and the pace of satellite-constellation launches, as both variables are primary levers for FEI-NY’s order pipeline; a 10% dip in defense spending would likely shave ~5% off FY 2025 revenue, whereas a 15% acceleration in satellite launches could add a comparable upside.
For a deeper, data-driven look at FEIM’s valuation metrics and peer comparison, you might find ValueRay’s analytical platform worth a quick glance.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 21.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -23.47 > 1.0 |
| NWC/Revenue: 44.74% < 20% (prev 38.94%; Δ 5.80% < -1%) |
| CFO/TA -0.03 > 3% & CFO -3.14m > Net Income 21.0m |
| Net Debt (5.41m) to EBITDA (9.17m): 0.59 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (9.76m) vs 12m ago 1.83% < -2% |
| Gross Margin: 39.22% > 18% (prev 0.39%; Δ 3883 % > 0.5%) |
| Asset Turnover: 82.16% > 50% (prev 77.39%; Δ 4.78% > 0%) |
| Interest Coverage Ratio: 70.28 > 6 (EBITDA TTM 9.17m / Interest Expense TTM 96.0k) |
Altman Z'' 3.47
| A: 0.34 (Total Current Assets 50.9m - Total Current Liabilities 19.7m) / Total Assets 92.3m |
| B: 0.07 (Retained Earnings 6.09m / Total Assets 92.3m) |
| C: 0.08 (EBIT TTM 6.75m / Avg Total Assets 85.0m) |
| D: 0.47 (Book Value of Equity 15.9m / Total Liabilities 33.8m) |
| Altman-Z'' Score: 3.47 = A |
Beneish M -2.11
| DSRI: 1.15 (Receivables 21.6m/16.2m, Revenue 69.9m/60.2m) |
| GMI: 1.00 (GM 39.22% / 39.38%) |
| AQI: 1.68 (AQ_t 0.29 / AQ_t-1 0.17) |
| SGI: 1.16 (Revenue 69.9m / 60.2m) |
| TATA: 0.26 (NI 21.0m - CFO -3.14m) / TA 92.3m) |
| Beneish M-Score: -2.11 (Cap -4..+1) = BB |
What is the price of FEIM shares?
Over the past week, the price has changed by -0.67%, over one month by -5.67%, over three months by +57.63% and over the past year by +199.31%.
Is FEIM a buy, sell or hold?
What are the forecasts/targets for the FEIM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38 | -27.2% |
| Analysts Target Price | 38 | -27.2% |
| ValueRay Target Price | 71.3 | 36.6% |
FEIM Fundamental Data Overview February 03, 2026
P/S = 7.36
P/B = 8.7682
Revenue TTM = 69.9m USD
EBIT TTM = 6.75m USD
EBITDA TTM = 9.17m USD
Long Term Debt = 8.40m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.08m USD (from shortTermDebt, last quarter)
Debt = 8.40m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.41m USD (from netDebt column, last quarter)
Enterprise Value = 274.8m USD (269.4m + Debt 8.40m - CCE 2.99m)
Interest Coverage Ratio = 70.28 (Ebit TTM 6.75m / Interest Expense TTM 96.0k)
EV/FCF = -43.35x (Enterprise Value 274.8m / FCF TTM -6.34m)
FCF Yield = -2.31% (FCF TTM -6.34m / Enterprise Value 274.8m)
FCF Margin = -9.07% (FCF TTM -6.34m / Revenue TTM 69.9m)
Net Margin = 30.12% (Net Income TTM 21.0m / Revenue TTM 69.9m)
Gross Margin = 39.22% ((Revenue TTM 69.9m - Cost of Revenue TTM 42.5m) / Revenue TTM)
Gross Margin QoQ = 38.16% (prev 36.79%)
Tobins Q-Ratio = 2.98 (Enterprise Value 274.8m / Total Assets 92.3m)
Interest Expense / Debt = 0.26% (Interest Expense 22.0k / Debt 8.40m)
Taxrate = 21.0% (US default 21%)
NOPAT = 5.33m (EBIT 6.75m * (1 - 21.00%))
Current Ratio = 2.59 (Total Current Assets 50.9m / Total Current Liabilities 19.7m)
Debt / Equity = 0.14 (Debt 8.40m / totalStockholderEquity, last quarter 58.5m)
Debt / EBITDA = 0.59 (Net Debt 5.41m / EBITDA 9.17m)
Debt / FCF = -0.85 (negative FCF - burning cash) (Net Debt 5.41m / FCF TTM -6.34m)
Total Stockholder Equity = 55.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 24.75% (Net Income 21.0m / Total Assets 92.3m)
RoE = 37.87% (Net Income TTM 21.0m / Total Stockholder Equity 55.6m)
RoCE = 10.55% (EBIT 6.75m / Capital Employed (Equity 55.6m + L.T.Debt 8.40m))
RoIC = 9.59% (NOPAT 5.33m / Invested Capital 55.6m)
WACC = 10.04% (E(269.4m)/V(277.8m) * Re(10.35%) + D(8.40m)/V(277.8m) * Rd(0.26%) * (1-Tc(0.21)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.90%
Fair Price DCF = unknown (Cash Flow -6.34m)
EPS Correlation: 57.67 | EPS CAGR: 153.3% | SUE: -2.01 | # QB: 0
Revenue Correlation: 81.93 | Revenue CAGR: 9.36% | SUE: N/A | # QB: 0
EPS current Year (2026-04-30): EPS=1.09 | Chg30d=-0.590 | Revisions Net=-1 | Growth EPS=-56.0% | Growth Revenue=-2.2%
EPS next Year (2027-04-30): EPS=1.35 | Chg30d=-0.400 | Revisions Net=-1 | Growth EPS=+23.8% | Growth Revenue=+17.9%